Compare Carvana Co (CVNA) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carvana Co vs Medtronic PLC — how do they compare? Carvana Co trades at $73.9 (market cap $79.69B), while Medtronic PLC trades at $90.9 (market cap $116.18B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays a 3.17% dividend while Carvana Co pays none. Which is the better fit depends on your goals.
| CVNA | MDT | |
|---|---|---|
Market Cap | $79.69B | $116.18B |
Sector | Consumer Cyclical | Health |
52-Week High | $95.69 | $105.35 |
52-Week Low | $56.27 | $73.75 |
Enterprise Value | $82.18B | $134.92B |
Dividend Yield | — | 3.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Carvana (CVNA) trades at $73.71, up 2.36% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong revenue growth to $20.32B in 2025 and net income of $1.41B, with recent earnings beats. Positive cash flow trends and a recent $1.66B term loan pricing (Business Wire, 2026-08-12) support liquidity, though valuation multiples remain elevated.
Outlook is mixed: robust growth and analyst consensus target of $87.18 suggest upside, but high P/E of 38.35 and profit margin compression risks warrant caution. Execution on hypergrowth strategy and debt management are key to sustaining momentum amid competitive pressures.
Medtronic (MDT) trades at $90.58, showing modest daily decline of -0.11% but maintaining strong technical momentum with bullish moving averages. The company demonstrates solid fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.55 beating expectations of $1.54, and robust profitability with 65.02% gross margins. Recent product innovations include FDA clearance for AI surgical platform and expanded CE Mark for cardiac ablation systems, positioning MDT for continued medical technology leadership.
MDT presents a compelling investment case with 60% analyst buy ratings and $98.75 consensus price target suggesting 9% upside. The stock offers dividend income with $0.72 quarterly payout and strong cash flow generation. Key risks include rising debt levels with debt-to-asset ratio increasing to 31.11% in 2025 and competitive pressures in medical technology sector. The combination of valuation discount to peers, consistent execution, and innovation pipeline supports positive medium-term outlook.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Carvana Co
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.
Read more on CVNA →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
